Testing effectiveness (Phase 2)Ended earlyNCT01545518
What this trial is testing
IVIG Treatment for Refractory Immune-Related Adult Epilepsy
Who this might be right for
Epilepsy, CryptogenicEpilepsy, PartialSeizure Disorder+2 more
Emory University 20